1
Exhibit 10 (1)
EMPLOYMENT AGREEMENT
THIS EMPLOYMENT AGREEMENT ("Agreement") is made and entered into by HYCOR
BIOMEDICAL INC., a Delaware corporation ("Company"), and J. ▇▇▇▇▇ ▇▇▇▇▇▇
("▇▇▇▇▇▇").
WHEREAS, ▇▇▇▇▇▇ serves as the President and Chief Executive Officer of the
Company pursuant to an employment agreement dated December 10, 1998;
WHEREAS, the parties hereto desire to modify the terms of the existing
employment agreement between ▇▇▇▇▇▇ and the Company.
NOW, THEREFORE, in consideration of the promises and covenants set forth in this
Agreement and for other valuable consideration, the parties agree as follows:
Prior Agreement: This Agreement supercedes and replaces in its entirety
the Employment Agreement executed December 10, 1998.
Employment: ▇▇▇▇▇▇ shall be employed as President and Chief Executive
Officer of the Company reporting to the Chairman, and shall faithfully and
diligently perform all duties and responsibilities required of such position
based upon the general direction of the Board of Directors from time to time,
including service on behalf of the Company's subsidiary and affiliated
companies.
Term: This Agreement and ▇▇▇▇▇▇'▇ employment as President and Chief
Executive Officer shall be for a term of two (2) years commencing on April 1,
2000 and expiring on April 1, 2002. Thereafter, the parties may renew this
Agreement upon mutually agreeable terms and conditions.
Compensation: In consideration for all services to be performed under
this Agreement, ▇▇▇▇▇▇ shall receive the following compensation:
Salary: ▇▇▇▇▇▇ shall be paid base salary at the rate of
$224,718.00 per year, subject to potential increases based upon annual
performance reviews.
Bonus: ▇▇▇▇▇▇ shall annually submit, within ten (10) days
prior to the commencement of a new fiscal year, a Bonus Plan to the Compensation
Committee of the Board of Directors for approval, under which ▇▇▇▇▇▇ shall
participate, based upon obtaining the agreed upon revenue, profit and stock
price milestones. Nothing herein or in said plan shall constitute a guarantee of
▇▇▇▇▇▇'▇ employment by the Company, or a limitation on the Company's rights
under this Agreement, or limitation on the Company's rights to amend or
terminate such plan.
1
2
Employee Benefit Plans: ▇▇▇▇▇▇ shall be entitled to
participate in all employee benefit plans, including group medical, dental,
visual, and life insurance, pension, profit sharing, group and individual
disability income, stock option, and other benefit plans, on terms commensurate
with the benefits awarded management personnel of comparable status with the
Company or any affiliate of the Company, but subject, on any termination, to
Section 5(e) below.
Expense Reimbursement: The Company shall reimburse ▇▇▇▇▇▇ for
all reasonable expenses that he necessarily incurs in connection with his
employment and for which he presents adequate documentation in accordance with
Company policies in effect from time to time.
Relocation Expenses: The Company shall reimburse ▇▇▇▇▇▇ on a
monthly basis for his monthly lease obligations (not to exceed $2,500) for a
furnished apartment in Southern California for up to two (2) years provided that
▇▇▇▇▇▇ remains employed hereunder. In addition, the Company shall pay directly
or shall reimburse ▇▇▇▇▇▇ for his reasonable relocation expenses upon
satisfactory proof thereof, up to a maximum of $50,000 (this includes any
amounts already paid or reimbursed through the execution of this Agreement).
Termination: This Agreement and ▇▇▇▇▇▇'▇ employment are subject to
immediate termination at any time as follows:
Death: This Agreement shall terminate immediately upon
▇▇▇▇▇▇'▇ death, in which event the Company's only obligations shall be (i) to
pay all compensation owing for services rendered by ▇▇▇▇▇▇ prior to the date of
his death; (ii) to continue paying ▇▇▇▇▇▇'▇ base salary to his estate for a
period of thirty (30) days after his death; and (iii) to make periodic
recoverable advances to ▇▇▇▇▇▇'▇ estate equivalent to ▇▇▇▇▇▇'▇ base salary for
ninety (90) days after said thirty (30) day period has lapsed, with such
advances to be repaid when insurance proceeds from a policy on ▇▇▇▇▇▇'▇ life
become available.
Disability: In the event that ▇▇▇▇▇▇ is disabled from
performing his assigned duties under this Agreement due to illness or injury for
a period in excess of one hundred eighty (180) days, the Company may place
▇▇▇▇▇▇ on an unpaid leave of absence for a period not to exceed six (6) months,
in which case the Company's only obligation shall be (i) to continue ▇▇▇▇▇▇'▇
group medical and life insurance for the duration of the leave; (ii) to pay the
bonus, if any, that ▇▇▇▇▇▇ would be entitled to under the terms of the bonus
plans referred to in Section 4(b) of this Agreement; and (iii) to allow ▇▇▇▇▇▇
to continue receiving benefits under the disability insurance and other employee
benefit plans in effect at the time of his disability in accordance with the
terms and conditions of such plans. The granting of a leave of absence does not
guarantee that ▇▇▇▇▇▇ will be returned to employment, and the Company reserves
the right to replace ▇▇▇▇▇▇ or to take other action in his absence due to
business necessity.
2
3
If ▇▇▇▇▇▇ is certified to return to work before his leave of absence expires,
and desires to do so, the following provisions shall apply: (i) the Company will
attempt to return ▇▇▇▇▇▇ to his same or similar position, provided this does not
result in undue hardship to the Company; and (ii) if the Company is unable to
reinstate ▇▇▇▇▇▇ because his position has been filled, then as a special
severance benefit, the Company shall pay a lump-sum severance payment equal to
twelve (12) months of ▇▇▇▇▇▇'▇ base salary as in effect immediately prior to the
commencement of ▇▇▇▇▇▇'▇ leave of absence. If ▇▇▇▇▇▇ is not certified to return
to work before his leave of absence expires, or does not desire to return, his
employment and this Agreement shall terminate upon the expiration of his leave
of absence.
Termination For Cause: The Company may terminate this
Agreement for cause immediately upon written notice to ▇▇▇▇▇▇ in the event
▇▇▇▇▇▇ (i) in the course of his duties engages in misconduct which has a
material adverse effect on the Company or its business, willfully breaches this
Agreement in any material respect or consistently or habitually neglects his
duties as a Company officer, or (ii) is finally convicted of a felony. In either
event, the Company's sole obligation to ▇▇▇▇▇▇ in lieu of all claims for
compensation or damages shall be to pay all compensation owing for services
rendered by ▇▇▇▇▇▇ prior to the date of termination under this subsection.
Termination Without Cause: The Company in its sole discretion
may terminate this Agreement without cause or prior warning immediately upon
written notice to ▇▇▇▇▇▇. For purposes of this Section 5(d), any resignation
following a substantial reduction in ▇▇▇▇▇▇'▇ salary, benefits (including the
failure of Company to include ▇▇▇▇▇▇ as a participant in its executive or
management bonus plans), duties or responsibilities shall constitute an
involuntary termination without cause. In the event of a termination under this
Section 5(d), the Company shall pay all compensation owing for services rendered
by ▇▇▇▇▇▇ prior to the date of termination, shall pay a lump-sum severance
benefit equal to (i) the number of months remaining of the term of this
Agreement or (ii) twelve (12) months, whichever is less, of ▇▇▇▇▇▇'▇ base salary
at the time of termination, and shall continue to provide ▇▇▇▇▇▇ at Company
expense all medical, disability and insurance benefits available to him at the
time of termination for the same number of months as used to calculate the
lump-sum severance benefit. As an additional severance payment, if the Company
has in effect at the time of any termination without cause under this Section
5(d) any bonus or incentive plan which provides for awards in cash and is based
on the Company's revenues or results of operations for a fiscal year, ▇▇▇▇▇▇
shall be entitled to an amount equal to a pro rata award based on the period of
the fiscal year for which he was employed if a termination under this Section
5(d) occurs after the completion of three fiscal quarters. Such severance shall
be payable at the same time, and computed on the same terms, as awards under the
plan in question, except for periods of service. Such payments and benefits
shall not entitle ▇▇▇▇▇▇ to any other benefits or compensation program available
to Company employees.
3
4
Change In Control:
If the Company undergoes a change in control, and
▇▇▇▇▇▇ is at such time employed by the Company, ▇▇▇▇▇▇ shall immediately be
entitled to a payment from the Company equal to 300 percent of the sum of his
current base salary and most recent bonus (the "Change Payment").
In the event that ▇▇▇▇▇▇ is terminated by the
Company within ninety (90) days before a change in control, ▇▇▇▇▇▇ shall receive
(i) the Change Payment, (ii) at Company expense, all medical, disability and
insurance benefits available to him at the time of such termination for a period
of twenty four (24) months after such termination or, if shorter, the maximum
period allowed under the Company's policies as then in effect or under
applicable law, (iii) acceleration of the vesting of all unvested stock options
granted to ▇▇▇▇▇▇ under the Company's stock option or other benefit plans so
that all such stock options will vest and be fully exercisable on the date of
such termination, (iv) extension of the post-termination exercise period for all
stock options granted to ▇▇▇▇▇▇ under the Company's stock option and other
benefit plans so that all such stock options will be exercisable for a period of
three months after the date of such termination (except that with respect to any
stock options having a post-termination exercise period in excess of three
months, such longer post-termination exercise period shall remain in effect),
and (v) a consulting agreement that entitles him to perform services for at
least three years after the change in control, at a minimum payment of $2,500
per day for a minimum of 20 days per year after the change in control, with
payments to him being made at least semiannually in advance.
In the event that ▇▇▇▇▇▇ resigns or is terminated
by the Company within twenty four (24) months on or after a change in control,
▇▇▇▇▇▇ shall receive, in addition to the Change Payment described in Section
5(e)(1), (i) at Company expense, all medical, disability and insurance benefits
available to him at the time of such termination or resignation for a period of
twenty four (24) months after such termination or resignation, or, if shorter,
the maximum period allowed under the Company's policies as then in effect or
under applicable law, (iii) acceleration of the vesting of all unvested stock
options granted to ▇▇▇▇▇▇ under the Company's stock option or other benefit
plans so that all such stock options will vest and be fully exercisable on the
date of such termination or resignation, (iv) extension of the post-termination
exercise period for all stock options granted to ▇▇▇▇▇▇ under the Company's
stock option and other benefit plans so that all such stock options will be
exercisable for a period of three months after the date of such termination or
resignation (except that with respect to any stock options having a
post-termination exercise period in excess of three months, such longer
post-termination exercise period shall remain in effect), and (v) a consulting
agreement that entitles him to perform services for at least three years after
the change in control, at a minimum payment of $2,500 per day for a minimum of
20 days per year after the change in control, with payments to him being made at
least semiannually in advance.
4
5
For purposes of this subsection, the term "change in control"
shall mean any change in control that the Company would be required to report in
response to Item 5(f) of Schedule 14A of Regulation 14A promulgated under the
Securities Exchange Act of 1934, as amended (the "Exchange Act"). Without
limiting the foregoing, a change in control shall also be deemed to have
occurred if (i) any "person" as defined in Section 13(d) and 14(d) of the
Exchange Act is or becomes, directly or indirectly, the "beneficial owner" as
defined in Rule 13 (d-3) under the Exchange Act of securities of the Company
which represent 25% or more of the combined voting power of the Company's then
outstanding securities; or (ii) during any period of two consecutive years,
individuals who at the beginning of said two year period constituted the Board
of Directors of the Company cease for any reason to constitute at least a
majority of the Board unless the election or nomination of each new director was
approved by a vote of at least two-thirds of the directors who were in office at
the beginning of said two year period.
▇▇▇▇▇▇ shall not be entitled to the benefits of this Section
5(e) if this Agreement and his employment are, prior to a Change of Control,
terminated pursuant to Section 5(a), (b) or (c).
In consideration for the benefits related to a change in
control described in this Section 5(e), ▇▇▇▇▇▇ agrees that upon the occurrence
of a potential change in control, he will not voluntarily terminate his
employment with the Company for a period of six (6) months after the potential
change in control. For purposes of this Agreement, a "potential change in
control" shall mean any of the following: (i) the execution of an agreement by
the Company that will result in a change in control, (ii) the Company announces
an intention to take action that will result in a change in control, or (iii)
with respect to this Agreement, the Board of Directors of the Company declares
that a potential change in control has occurred. In addition, if following a
change in control any dispute arises between the Company and ▇▇▇▇▇▇ as to the
terms or interpretation of this Agreement, including any action that ▇▇▇▇▇▇ may
take to enforce or defend himself against the terms of this Agreement, ▇▇▇▇▇▇
shall be reimbursed for all costs, expenses, and attorneys' fees arising from
such dispute, provided that he obtains either a final judgment or settlement
substantially in his favor.
Company's Obligations Under This Agreement Exclusive: The
benefits set forth in subsections (a) through (e) above (which benefits, in the
event of termination pursuant to subsections (a), (c), (d) or (e), include
payment for services rendered prior to termination as provided in such
subsections), as applicable, constitute the sole obligations of the Company to
▇▇▇▇▇▇ upon a termination and are in lieu of any damages or other compensation
that ▇▇▇▇▇▇ may claim under other Company policies in connection with this
Agreement. The benefits on termination in this Agreement are in substitution for
any severance or termination benefits otherwise available under Company policies
of general application. ▇▇▇▇▇▇ expressly acknowledges that certain Company
benefit or incentive plans provide for vesting in, or award of, benefits based
on employment on or through particular dates and that nothing in this Agreement
5
6
entitles him to partial vesting or partial awards under such plans. Any payments
under Section 5(d) relating to any incentive or bonus plan are expressly
acknowledged to be benefits under this Agreement and not an interpretation or
modification of any such plan.
Resignation As Officer: In the event of any termination
pursuant to this Section 5, ▇▇▇▇▇▇ shall be deemed to have resigned as an
officer of the Company if he was serving in such capacity at the time of
termination.
Confidentiality: ▇▇▇▇▇▇ acknowledges and agrees that he has been and
will continue to be entrusted with certain trade and proprietary information
regarding the products, processes, methods of manufacture and delivery,
know-how, designs, formula, work in progress, research and development, computer
software and data bases, copyrights, trademarks, patents, marketing techniques,
and future business plans, as well as customer lists and information concerning
the identity, needs, and desires of actual and potential customers of the
Company and its subsidiaries, joint venturers, partners, and other affiliated
persons and entities, all of which derive significant economic value from not
being generally known to others outside the Company ("Confidential
Information").
During the entire term of his employment with the Company and
for two years thereafter, ▇▇▇▇▇▇ shall not disclose or exploit any Confidential
Information except for the sole benefit of the Company or with its express
written consent.
During the entire term of his employment by the Company and
for one year thereafter, ▇▇▇▇▇▇ shall not directly or indirectly solicit any
person or company known by ▇▇▇▇▇▇ to be an actual or actively sought customer of
the Company or its subsidiary and affiliated companies for any business is known
by ▇▇▇▇▇▇ to be conducted or under development by the Company, except for the
sole benefit of the Company or with its express written consent.
During the entire term of his employment by the Company and
for one year thereafter, ▇▇▇▇▇▇ shall not induce or attempt to induce any
employee of the Company to leave the Company's employ except for the sole
benefit of the Company or with its express written consent.
In the event any provision in this Section 6 is more
restrictive than allowed by the law of any jurisdiction in which the Company
seeks enforcement, such provision shall be deemed amended and shall then be
fully enforceable to the extent permitted by such law.
▇▇▇▇▇▇ acknowledges and agrees that any violation of this
Section 6 would cause immediate irreparable damage to the Company, and that it
would be extremely difficult or impossible to determine the amount of damage
caused to the
6
7
Company. ▇▇▇▇▇▇ therefore agrees that the Company's remedies at law are
inadequate, and hereby consents to issuance of a temporary restraining order,
preliminary and permanent injunction, and other appropriate relief to restrain
any actual or threatened violation of this Section, without limiting any
remedies the Company may have at law or in equity.
Inventions: Any and all patents, copyrights, trademarks, inventions,
discoveries, developments, or trade secrets developed or perfected by ▇▇▇▇▇▇
during or as the result of his employment with the Company shall constitute the
sole and exclusive property of the Company. ▇▇▇▇▇▇ shall disclose all such
matters to the Company, assign all right, title and interest he may have in
them, and cooperate with the Company in obtaining and perfecting any patent,
copyright, trademark, or other legal protection. This Section 7 shall not apply
to any invention which qualifies fully under California Labor Code Section 2870,
a true copy of which is attached to this Agreement as Exhibit A.
Conflict Of Interest: During the term of this Agreement, ▇▇▇▇▇▇ shall
devote his time, ability, and attention to the business of the Company, and
shall not accept other employment or engage in any other outside business
activity which interferes with the performance of his duties and
responsibilities under this Agreement or which involves actual or potential
competition with the business of the Company, except with the express written
consent of the Board of Directors.
Employee Benefit Plans: All of the employee benefit plans referred to
or contemplated by this Agreement shall be governed solely by the terms of the
underlying plan documents and by applicable law. Nothing in this Agreement shall
impair the Company's right to amend, modify, replace and terminate any and all
such plans in its sole discretion as provided by law, or to terminate this
Agreement in accordance with its terms. This Agreement is for the sole benefit
of ▇▇▇▇▇▇ and the Company, and is not intended to create an employee benefit
plan or to modify the term of existing plans.
Parachute Limitation: The payments and benefits ▇▇▇▇▇▇ is entitled to
under this Agreement and all other contracts, arrangements, or programs shall
not, in the aggregate, exceed the maximum amount that may be paid to ▇▇▇▇▇▇
without triggering golden parachute penalties under Section 280G and related
provisions of the Internal Revenue Code, as determined in good faith by the
Company's independent auditors. If ▇▇▇▇▇▇'▇ benefits must be cut back to avoid
triggering such penalties, ▇▇▇▇▇▇'▇ benefits shall be cut back in the priority
order designated by ▇▇▇▇▇▇ or, if ▇▇▇▇▇▇ fails promptly to designate an order,
in the priority order designated by the Company. If an amount in excess of the
limit set forth in this Section is paid to ▇▇▇▇▇▇, ▇▇▇▇▇▇ must repay the excess
amount to the Company upon demand, with interest at the rate provided for in
Internal Revenue Code Section 1274(b)(2)(B). ▇▇▇▇▇▇ and the Company agree
reasonably to cooperate with each other in connection with any administrative or
judicial proceedings concerning the existence or amount of golden parachute
penalties
7
8
with respect to payments or benefits ▇▇▇▇▇▇ receives. No part of this Agreement
is made in contemplation of, or anticipates any presently impending change in,
ownership or control. Further, no payment to be made to ▇▇▇▇▇▇ in accordance
with any provision of this Agreement, except Paragraph 4(e) entitled
"Termination Following Change in Control," is contingent upon a change in
ownership or control of the Company. This Agreement does not provide for
payments to ▇▇▇▇▇▇ which are significantly different in amount, timing, terms,
or conditions from those provided under contracts entered into by the Company
and individuals performing comparable services.
Assignment: This Agreement may not be assigned by ▇▇▇▇▇▇, but may be
assigned by the Company to any successor in interest to its business. In the
event the Company does not survive any merger, acquisition, or other
reorganization, it shall make a reasonable effort to obtain an assumption of
this Agreement by the surviving entity in such merger, acquisition, or other
reorganization, but the failure to obtain such assumption shall not prevent or
delay such merger, acquisition, or other reorganization or relieve the Company
of its other obligations under this Agreement. This Agreement shall bind and
inure to the benefit of the Company's successors and assigns, as well as
▇▇▇▇▇▇'▇ heirs, executors, administrators, and legal representatives.
Notices: All notices required by this Agreement may be delivered by
first class mail at the following addresses:
To the Company: Hycor Biomedical Inc.
▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇
To ▇▇▇▇▇▇: J. ▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇
Amendment: This Agreement may be modified only by written agreement
signed by the party against whom any amendment is to be enforced.
Choice Of Law: This Agreement shall be governed by the laws of the
State of California.
Partial Invalidity: In the event any provision of this Agreement is
void or unenforceable, the remaining provisions shall continue in full force and
effect.
Waiver: No waiver of any breach of this Agreement shall constitute a
waiver of any subsequent breach.
8
9
"Company"
HYCOR BIOMEDICAL INC.
Dated: April 30, 2000 By: /s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
-----------------------------------
Name: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇
Title: Chairman, Compensation Committee
"▇▇▇▇▇▇"
J. ▇▇▇▇▇ ▇▇▇▇▇▇
Dated: April 30, 2000 /s/ J. ▇▇▇▇▇ ▇▇▇▇▇▇
--------------------------------------
9
10
EXHIBIT A
CALIFORNIA LABOR CODE SECTION 2870
EMPLOYMENT AGREEMENTS; ASSIGNMENT OF RENTS
(a) Any provision in an employment agreement which provides that an employee
shall assign, or offer to assign, any of his or her rights in an invention to
his or her employer shall not apply to an invention that the employee developed
entirely on his or her own time without using the employer's equipment,
supplies, facilities, or trade secret information except for those inventions
that either:
(1) Relate at the time of conception or reduction to practice
of the invention to the employer's business, or actual or
demonstrably anticipated research or development of the
employer; or
(2) Result from any work performed by the employee for the
employer.
(b) To the extent a provision in an employment agreement purports to
require an employee to assign an invention otherwise excluded from
being required to be assigned under subdivision (a), the provision
is against the public policy of this state and is unenforceable.
10